Stryker Corp
SYKToday
-1.58%
5 Days
-8.33%
1 Month
-10.17%
6 Months
-16.40%
Year to Date
-13.29%
1 Year
-21.95%
Stryker Corp Stock (SYK) Closed Down by 3.61% on Aug 20: A Full Analysis
• Stryker shares faced volatility and profit-taking despite securing a U.S. defense contract modification. • Investors remain cautious regarding operational disruptions, cyber incident costs, and supply chain bottlenecks. • The company reported annual revenue of $25.12B and a net profit of $3.25B.
CVS Health Corp Stock (CVS) Moved Down by 3.46% on Aug 17: A Full Analysis
• CVS Health faced selling pressure despite raising its full-year earnings guidance. • Investors remain cautious regarding medical cost trends and Caremark structural changes. • Technical indicators show negative momentum with a MACD value of -2.245.
Stryker Corp Stock (SYK) Moved Up by 4.41% on Aug 3: What Investors Need To Know
• Stryker exceeded second-quarter earnings expectations across MedSurg and Neurotechnology segments. • Management raised full-year earnings guidance citing operational efficiencies and market share gains. • Analysts maintain a Buy rating with an average price target of $385.60.
Stryker Corp Stock (SYK) Moved Down by 6.58% on Jul 31: What Investors Need To Know
• Stryker's stock declined following an earnings miss and contraction in operating margins. • Management lowered forward-looking guidance due to inflationary pressures and cooling elective procedure demand. • Analysts reduced price targets as automated selling programs accelerated downward stock momentum.
Stryker Corp Stock (SYK) Moved Up by 3.15% on Jul 24: Facts Behind the Movement
• Stryker exceeded second-quarter earnings expectations driven by strong MedSurg and Neurotechnology segment performance. • Management raised full-year organic growth and earnings guidance following higher elective procedure volumes. • Analyst upgrades and increased institutional demand contributed to positive momentum in Stryker shares.
Stryker Corp Stock (SYK) Closed Up by 3.21% on Jul 23: Drivers Behind the Movement
• Stryker’s second-quarter earnings exceeded analyst expectations with growth in MedSurg and Neurotechnology. • Management raised full-year earnings guidance citing strong demand and elective procedure recovery. • Analysts increased price targets following positive performance and consistent robotic technology market expansion.
Stryker Corp's Score
Media Coverage
Analyst Rating
Stryker Corp Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Stryker Corp Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 5.84% |
| Brown (John W) | 5.23% |
| BlackRock Institutional Trust Company, N.A. | 4.39% |
| Greenleaf Trust | 4.16% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 45.13% |
| Investment Advisor/Hedge Fund | 21.50% |
| Bank and Trust | 6.47% |
| Individual Investor | 5.39% |
Related Instruments
Popular Instruments
